60 results
Page 2 of 3
8-K
EX-99.1
vwtdl9esr
10 Nov 22
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Third Quarter of 2022
7:04am
8-K
EX-99.1
4i51vk km77cqys
12 Sep 22
Regulation FD Disclosure
7:16am
8-K
EX-99.1
bhuxd7x
10 Aug 22
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2022; Provides Program Update for ZF874
12:00am
S-3
770cyvot7sbqghzva
1 Jul 22
Shelf registration
4:06pm
8-K
EX-99.1
deub 7ul9t0bk
1 Jul 22
Centessa Pharmaceuticals Announces Appointment of Dr. Mathias Hukkelhoven
8:45am
DEFA14A
7w158
9 Jun 22
Additional proxy soliciting materials
9:06am
8-K
fcbmzhbco
2 Jun 22
Cost Associated with Exit or Disposal Activities
6:33am
8-K
EX-99.2
yfq2ncoe12r7b
2 Jun 22
Cost Associated with Exit or Disposal Activities
6:33am
8-K
EX-99.1
70xj zqxesk1
2 Jun 22
Cost Associated with Exit or Disposal Activities
6:33am
DEF 14A
benz r1ieo6mgg3hd
23 May 22
Definitive proxy
8:00am
8-K
EX-99.1
mulj7k
16 May 22
Centessa Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Updates
7:14am
8-K
EX-99.1
u2rho8r867d5 07nqfp
30 Mar 22
Centessa Pharmaceuticals Reports Fourth Quarter and 2021 Financial Results and Provides Business Update
4:06pm
8-K
EX-99.2
txiemncgxcgr1y0
30 Mar 22
Centessa Pharmaceuticals Reports Fourth Quarter and 2021 Financial Results and Provides Business Update
4:06pm
10-K
EX-10.35
puw377vr
30 Mar 22
Annual report
12:00am
10-K
mr92aa3 up27lx5
30 Mar 22
Annual report
12:00am
8-K/A
EX-99.1
dou0khly we3b3y3ikih
14 Mar 22
Unregistered Sales of Equity Securities
7:38am
8-K
EX-99.1
8hgfj
24 Feb 22
Unregistered Sales of Equity Securities
7:37am